With its outstanding investment team and unique multimanager approach, Primecap Odyssey Growth is exemplary.
PRIMECAP Odyssey Growth POGRX
- NAV / 1-Day Return 36.31 / −0.41 %
- Total Assets 6.2 Bil
-
Adj. Expense Ratio
- Expense Ratio 0.660%
- Distribution Fee Level Below Average
- Share Class Type No Load
- Category Large Growth
- Investment Style Large Growth
- Min. Initial Investment 2,000
- Status Open
- TTM Yield 0.44%
- Turnover 7%
USD | NAV as of Apr 19, 2024 | 1-Day Return as of Apr 19, 2024, 10:18 PM GMT+0
Morningstar’s Analysis POGRX
Will POGRX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 30.5
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Eli Lilly and Co | 7.64 | 523.4 Mil | Healthcare |
Splunk Inc | 3.38 | 231.2 Mil | Technology |
Biogen Inc | 2.97 | 203.5 Mil | Healthcare |
AECOM | 2.79 | 191.4 Mil | Industrials |
Biomarin Pharmaceutical Inc | 2.37 | 162.2 Mil | Healthcare |
Micron Technology Inc | 2.33 | 159.9 Mil | Technology |
Raymond James Financial Inc | 2.32 | 158.6 Mil | Financial Services |
Microsoft Corp | 2.28 | 156.4 Mil | Technology |
Amgen Inc | 2.27 | 155.5 Mil | Healthcare |
Flex Ltd | 2.10 | 143.7 Mil | Technology |